D.E. Shaw & Co
GNLX icon

D.E. Shaw & Co’s Genelux GNLX Stock Holding History

D.E. Shaw & Co’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-55,012
Closed -$130K – 4561
2024
Q3 		$130K Buy
55,012
+27,905
+103% +$61.4K ﹤0.01% 4227
2024
Q2 		$52.9K Sell
27,107
-8,805
-25% -$29.9K ﹤0.01% 4213
2024
Q1 		$231K Buy
+35,912
New +$326K ﹤0.01% 3868

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PWM
Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co's GNLX Position: Q4 2024 in Review

D.E. Shaw & Co sold out of Genelux (GNLX) in Q4 2024, closing a stake of 55,012 shares — an estimated $130K sold.

D.E. Shaw & Co first reported a position in GNLX in Q1 2024 and held it in 3 quarters. The position peaked at $231K in Q1 2024. 58 funds tracked by Wall St. Rank hold GNLX as of Q4 2024.

  • D.E. Shaw & Co reported no remaining Genelux position as of Q4 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 55,012 Genelux shares in Q4 2024, an estimated $130K.
  • D.E. Shaw & Co first reported a position in Genelux in Q1 2024 and held it in 3 quarters.
  • D.E. Shaw & Co's Genelux position peaked at $231K in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Genelux as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.